fashion -WSS

fashion

author：hotspot 2025-08-19 18:02:41 - browse：923

Medicare generally pays far more for CAR-T drugs that are administered in outpatient departments than it does for inpatient care. Adobe

WASHINGTON — Hospitals for years have complained that Medicare pays so little for CAR-T cancer treatments that they sometimes lose money administering the incredibly expensive treatments. But that could soon change: if drug companies succeed in making the cancer treatments safer, hospitals could provide them more often in outpatient departments, where payment is higher.

CAR-T uses the body’s own immune system to kill cancerous cells. The procedure, regulated as a drug, involves taking T cells from a patient’s blood, adding chimeric antigen receptors (CAR) to the T cells that kill cancer, and injecting the CAR-T treatment back into the patient.

It’s worked wonders in many cancer patients who have run out of options. But right now it’s almost exclusively administered in hospitals, because the side effects can require aggressive treatments. In many cases, the CAR-T cells trigger immune reactions that can be life-threatening.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Immune cells and nerve overgrowth may explain recurring UTI pain

hotspot

WSS

Medicare Advantage overpayments discussion gets experts fired up

Medicare Advantage overpayments discussion gets experts fired up

American taxpayers paid $1.8 trillion in health care costs in 2022

Harvard's David Sinclair gets blowback over aging

Profiling embryos to choose those with higher IQs is almost a reality

Fauci's latest grilling in Congress: 9 hours, behind closed doors

entertainment

fashion

Wikipedia

Moonlake's readout produced a cash windfall. Risks remain

Why Talkspace is targeting Medicare, a tricky market

How to save PrEP access — and even expand it

Biden's 'march

After affirmative action ruling, medical educators look to 'holistic review'

$1 billion proposal to grow Boston, Massachusetts biotech

ChatGPT in medicine: STAT answers readers' burning questions

He's 19 months old and has one of the world’s rarest diseases

Drug repurposing or repositioning? The language matters

Pregnant women don't need prenatal multivitamins, study concludes

knowledge

Gene therapy denied for Afghan refugee whose father aided U.S.

American taxpayers paid $1.8 trillion in health care costs in 2022

Florida health officials providing scant details on measles cases

Change Healthcare: What is it, why does its cyberattack matter?

Boston Scientific acquires urology company Axonics for $3.7 billion

The untold story of TV’s first prescription drug ad

entertainment

hotspot

hotspot

entertainment